Haloperidol Krka

Haloperidol Krka is a prescription oral medication that contains the antipsychotic active ingredient haloperidol. It is manufactured by the Krka pharmaceutical company and is marketed within the European Union. The product is supplied as an oral dosage form, though the exact strength is not specified in the available information. Haloperidol Krka is classified as a butyrophenone antipsychotic and is available only with a prescription in many clinical settings.

Haloperidol Krka is indicated for several psychiatric conditions where dopamine blockade is therapeutic.

- Schizophrenia (including maintenance treatment) - Acute psychotic episodes - Manic episodes of bipolar disorder - Severe agitation requiring rapid control - Tourette syndrome (symptom management)

Side effects of haloperidol may vary in frequency and severity; they are typically categorized as common or serious.

Common: - Drowsiness or sedation - Extrapyramidal symptoms such as tremor or rigidity - Dry mouth - Constipation - Blurred vision

Serious: - Tardive dyskinesia (involuntary movements) - Neuroleptic malignant syndrome (fever, muscle rigidity) - Cardiac arrhythmias (QT prolongation)

When prescribing Haloperidol Krka, clinicians consider several precautions to minimize risks and ensure safe use.

- Assess cardiovascular status, especially for QT prolongation risk - Evaluate for history of movement disorders or tardive dyskinesia - Use the lowest effective dose for the shortest duration needed - Monitor for signs of neuroleptic malignant syndrome - Caution in patients with hepatic or renal impairment - Avoid abrupt discontinuation to reduce withdrawal or relapse

Haloperidol can interact with other medicines, influencing its effectiveness or safety profile.

Avoid: - Other dopamine antagonists or antipsychotics - Medications that prolong QT interval (e.g., certain antiarrhythmics) - Strong CYP3A4 inhibitors (e.g., ketoconazole)

Use with caution: - CYP3A4 inducers (e.g., carbamazepine) - CNS depressants such as benzodiazepines or opioids - Anticholinergic agents (may mask extrapyramidal symptoms)